Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst - Novavax (NASDAQ:NVAX), Sanofi (NASDAQ:SNY)

Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst - Novavax (NASDAQ:NVAX), Sanofi (NASDAQ:SNY)

Bank of America Securities writes that SMid-cap biotech, companies with small to mid-sized market capitalizations, had a rocky start to the year. Many companies in the coverage are down 20-40% year-to-date (NBI: -2.35%). Tariff concerns and the U.S. Food and Drug Administration (FDA) shakeup added further near-term uncertainty to an already challenging already challenging outlook. Earlier this week, Peter Marks resigned from his role at the FDA’…